Tibet Aim Pharm Inc Cash Flow Conversion Efficiency

Latest as of September 2025: 0.109x

Tibet Aim Pharm Inc cash flow conversion efficiency. Based on the latest financial reports, Tibet Aim Pharm Inc (002826) has a cash flow conversion efficiency ratio of 0.109x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥87.55 Million ≈ $12.81 Million USD) by net assets (CN¥802.15 Million ≈ $117.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Tibet Aim Pharm Inc (2013–2025)

Cash flow conversion efficiency of Tibet Aim Pharm Inc from 2013 to 2025. This chart illustrates how Tibet Aim Pharm Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Tibet Aim Pharm Inc (002826) share price today for real-time trading data and today's change.

Tibet Aim Pharm Inc Cash Flow Conversion Ratio Explained

Tibet Aim Pharm Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Tibet Aim Pharm Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tibet Aim Pharm Inc ranked by their cash flow conversion efficiency. Also see how much is Tibet Aim Pharm Inc worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Community Healthcare Trust Inc NYSE:CHCT	0.042x
Melcor Developments Ltd. TO:MRD	-0.004x
Nuveen Variable Rate Preferred & Income Fund NYSE:NPFD	0.113x
Eurocrane China Co Ltd SHG:603966	0.072x
EUROKAI GmbH & Co. KGaA F:EUK3	0.017x
Shanghai Haishun New Pharmaceutical Packaging Co Ltd SHE:300501	0.056x
Once Upon a Farm, PBC NYSE:OFRM	0.054x
Shanghai Rongtai Health Tech SHG:603579	-0.007x

Annual Cash Flow Conversion Efficiency for Tibet Aim Pharm Inc (2013–2025)

The table below shows the annual cash flow conversion efficiency of Tibet Aim Pharm Inc from 2013 to 2025. Review 002826 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥816.02 Million ≈ $119.41 Million	CN¥123.72 Million ≈ $18.10 Million	0.152x	+1.31%
2024-12-31	CN¥745.58 Million ≈ $109.10 Million	CN¥111.57 Million ≈ $16.33 Million	0.150x	-32.74%
2023-12-31	CN¥750.06 Million ≈ $109.76 Million	CN¥166.88 Million ≈ $24.42 Million	0.222x	+143.77%
2022-12-31	CN¥750.00 Million ≈ $109.75 Million	CN¥68.45 Million ≈ $10.02 Million	0.091x	-39.99%
2021-12-31	CN¥720.11 Million ≈ $105.37 Million	CN¥109.52 Million ≈ $16.03 Million	0.152x	+2.73%
2020-12-31	CN¥687.15 Million ≈ $100.55 Million	CN¥101.74 Million ≈ $14.89 Million	0.148x	+63.10%
2019-12-31	CN¥652.17 Million ≈ $95.43 Million	CN¥59.20 Million ≈ $8.66 Million	0.091x	+321.64%
2018-12-31	CN¥618.40 Million ≈ $90.49 Million	CN¥13.31 Million ≈ $1.95 Million	0.022x	-83.16%
2017-12-31	CN¥604.53 Million ≈ $88.46 Million	CN¥77.29 Million ≈ $11.31 Million	0.128x	+24.19%
2016-12-31	CN¥555.44 Million ≈ $81.28 Million	CN¥57.18 Million ≈ $8.37 Million	0.103x	+186.07%
2015-12-31	CN¥248.25 Million ≈ $36.33 Million	CN¥-29.69 Million ≈ $-4.34 Million	-0.120x	-1080.84%
2014-12-31	CN¥179.12 Million ≈ $26.21 Million	CN¥2.18 Million ≈ $319.61K	0.012x	-98.33%
2013-12-31	CN¥71.66 Million ≈ $10.49 Million	CN¥52.24 Million ≈ $7.64 Million	0.729x	--

About Tibet Aim Pharm Inc

SHE:002826 China Drug Manufacturers - Specialty & Generic

Market Cap

$415.74 Million

CN¥2.84 Billion CNY

Market Cap Rank

#12910 Global

#3770 in China

Share Price

CN¥14.90

Change (1 day)

+2.69%

52-Week Range

CN¥14.51 - CN¥22.24

All Time High

CN¥32.76